Skip to Main Content

Paper Details

Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection.
Clin Infect Dis
8
2022
Author NameAffiliation
Manjusha Gaglani
Manjusha GaglaniTexas A&M University College of Medicine
Natalie J ThornburgCenters for Disease Control and Prevention COVID-19 Response Team
Janko Nikolich-ZugichThe Mel and Enid Zuckerman College of Public Health and the College of Medicine, University of Arizona
Jennifer K MeeceMarshfield Clinic Research Institute
  • 1 - 5

Datasets

Release 1.2